J Edward Puzas Selected Research

J Edward Puzas Research Topics

Disease

7	Bone Resorption 08/2018 - 02/2002
6	Neoplasms (Cancer) 08/2018 - 01/2002
4	Pain (Aches) 10/2008 - 01/2002
4	Osteolysis 04/2005 - 02/2002
3	Osteoporosis 01/2017 - 03/2010
3	Arthritis (Polyarthritis) 10/2008 - 04/2006
3	Hypertrophy 05/2004 - 06/2002
3	Inflammation (Inflammations) 07/2002 - 03/2002
2	Breast Neoplasms (Breast Cancer) 08/2018 - 04/2005
2	Neoplasm Metastasis (Metastasis) 04/2006 - 10/2003
1	Virus Diseases (Viral Diseases) 01/2021
1	Heart Failure 01/2021
1	Pulmonary Hypertension 01/2021
1	Hyperoxia 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Tibial Fractures (Fracture, Tibial) 11/2014
1	Osteoarthritis 09/2011
1	Joint Diseases (Joint Disease) 09/2011
1	Back Pain (Backache) 03/2010
1	Musculoskeletal Diseases (Musculoskeletal Disease) 03/2010
1	Arthralgia (Joint Pain) 10/2008
1	Crush Injuries 08/2008
1	Wounds and Injuries (Trauma) 08/2008
1	Peripheral Nerve Injuries 08/2008
1	Cartilage Diseases (Cartilage Disease) 07/2004
1	Adenocarcinoma 10/2003
1	Prostatic Neoplasms (Prostate Cancer) 10/2003
1	Prosthesis Failure 02/2002
1	Osteoid Osteoma 01/2002

Drug/Important Bio-Agent (IBA)

3	Transcription Factors (Transcription Factor)IBA 01/2021 - 10/2003
3	CytokinesIBA 04/2005 - 03/2002
2	EnzymesIBA 01/2018 - 04/2005
2	Tartrate-Resistant Acid PhosphataseIBA 01/2018 - 02/2002
2	Teriparatide (Parathar)FDA Link 09/2011 - 03/2010
2	Interleukin-1beta (Interleukin 1 beta)IBA 10/2008 - 04/2006
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2006 - 01/2002
2	Proteins (Proteins, Gene)FDA Link 04/2006 - 03/2002
2	Transforming Growth Factor beta (TGF-beta)IBA 07/2004 - 05/2004
2	Dinoprostone (PGE2)FDA Link 05/2004 - 01/2002
2	TitaniumIBA 05/2002 - 02/2002
2	RANK LigandIBA 03/2002 - 03/2002
1	Oxygen (Dioxygen)IBA 01/2021
1	PPAR gammaIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 08/2018
1	Calcitriol (Calcijex)FDA LinkGeneric 08/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2018
1	SteroidsIBA 01/2017
1	GlucocorticoidsIBA 01/2017
1	Parathyroid Hormone (Parathormone)IBA 09/2011
1	Pharmaceutical PreparationsIBA 03/2010
1	Erythropoietin FDA Link 08/2008
1	salicylhydroxamic acid (SHAM)IBA 08/2008
1	Opioid Receptors (Opioid Receptor)IBA 06/2007
1	mu Opioid Receptors (mu Opioid Receptor)IBA 06/2007
1	Neurotransmitter Agents (Neurotransmitter)IBA 04/2006
1	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 04/2006
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 04/2006
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 04/2006
1	Calcitonin Gene-Related PeptideIBA 04/2006
1	Caspase 3 (Caspase-3)IBA 04/2005
1	NF-KappaB Inhibitor alphaIBA 04/2005
1	Interleukin-6 (Interleukin 6)IBA 04/2005
1	NF-kappa B (NF-kB)IBA 04/2005
1	Azacitidine (5 Azacytidine)FDA Link 05/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2002
1	DNA (Deoxyribonucleic Acid)IBA 06/2002
1	Collagen Type XIBA 06/2002
1	Parathyroid Hormone-Related ProteinIBA 06/2002
1	Egtazic Acid (EGTA)IBA 06/2002
1	Annexin A5IBA 06/2002
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 06/2002
1	Interleukin-10 (Interleukin 10)IBA 05/2002
1	Therapeutic UsesIBA 03/2002
1	Complement Factor B (Factor B)IBA 03/2002
1	LigandsIBA 03/2002
1	OsteoprotegerinIBA 03/2002
1	Rank-FcIBA 02/2002
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 02/2002
1	Cyclooxygenase 1IBA 01/2002
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2002
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2002
1	ProstaglandinsIBA 01/2002
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2002

Therapy/Procedure

5	Therapeutics 08/2018 - 04/2006
1	Resistance Training 08/2018
1	Denervation 08/2008
1	Replacement Arthroplasty 05/2002
1	Bone-Implant Interface 03/2002
1	Arthroplasty 02/2002
1	Radiotherapy 01/2002